Letters in Drug Design & Discovery

Editor-in-Chief:

George Perry
University of Texas
San Antonio, TX
USA

Back

Become EABM
Become Reviewer

Potassium Channel Openers: The Case of BK Channel Activators

Volume:3   Issue:4
Pp: 210-218
A. Nardi, V. Calderone and S.- P. Olesen
DOI: 10.2174/157018006776743242

Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

Volume:3   Issue:4
Pp: 236-241
G. Merino, R. Real, A. J. Molina, M. M. Pulido, J. G. Prieto and A. I. Alvarez
DOI: 10.2174/157018006776743170

Targeting the Epigenome in Hematopoietic Malignancies

Volume:3   Issue:4
Pp: 242-252
E. Jost, R. Osieka and O. Galm
DOI: 10.2174/157018006776743251

Structural Analysis of Mogrol and its Glycosides as Inhibitors of Animal DNA Polymerase and Human Cancer Cell Growth

Volume:3   Issue:4
Pp: 253-260
Yoshiyuki Mizushina, Toshihiro Akihisa, Yousuke Hayakawa, Toshifumi Takeuchi, Isoko Kuriyama, Yuko Yonezawa, Masaharu Takemura, Ikuo Kato, Fumio Sugawara and Hiromi Yoshida
DOI: 10.2174/157018006776743224

Hologram QSAR Studies on Farnesoid X Receptor Activators

Volume:3   Issue:4
Pp: 261-267
Kathia M. Honorio, Richard C. Garratt, Igor Polikarpov and Adriano D. Andricopulo
DOI: 10.2174/157018006776743206

Recent Developments in Natural and Synthetic Drug Research for Alzheimers Disease

Volume:3   Issue:4
Pp: 268-274
Gurdal Orhan, Ilkay Orhan and Bilge Sener
DOI: 10.2174/157018006776743215

Alternative Albendazole Polybutylcyanoacrylate Nanoparticles Preparation, Pharmaceutical Properties and Tissue Distribution in Rats

Volume:3   Issue:4
Pp: 275-280
Xue-Nong Zhang, Li-Hua Tang, Jin-Hong Gong, Xiang-Yi Xu and Qiang Zhang
DOI: 10.2174/157018006776743198

Pyrazoloquinazoline Tricyclic System as Novel Scaffold to Design New Kinase CK2 Inhibitors

Volume:3   Issue:4
Pp: 281-284
Stefano Moro, Flavia Varano, Giorgio Cozza, Mario A. Pagano, Giuseppe Zagotto, Adriana Chilin, Adriano Guiotto, Daniela Catarzi, Vittoria Calotta and Lorenzo A. Pinna
DOI: 10.2174/157018006776743233